Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 9/20 | 0.37 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CCKAR | P32238 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 2/20 | 0.31 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29514126 | 1.00 | PTGDR2 (0.37) | PTGDR2SRCCYP2C19CCKARRECQL | |
| SCHEMBL2986594 | 0.87 | PTGDR2 (0.42) | PTGDR2SRCCYP2C19CCKARHTR6 | |
| SCHEMBL4602394 | 0.86 | PTGDR2 (0.39) | PTGDR2SRCCYP2C19CCKARRECQL | |
| SCHEMBL26103824 | 0.84 | PTGDR2 (0.38) | PTGDR2SRCCYP2C19HTR6PIK3C3 | |
| SCHEMBL30361980 | 0.84 | PTGDR2 (0.38) | PTGDR2SRCCYP2C19HTR6PIK3C3 | |
| SCHEMBL15644711 | 0.83 | PIK3C3 (0.41) | PTGDR2SRCCYP2C19CCKARRECQL | |
| SCHEMBL4318668 | 0.83 | PTGDR2 (0.37) | PTGDR2SRCCYP2C19RECQLHTR6 | |
| SCHEMBL15646942 | 0.82 | PTGDR2 (0.38) | PTGDR2SRCCYP2C19CCKARRECQL | |
| SCHEMBL15645387 | 0.81 | PTGDR2 (0.36) | PTGDR2SRCCCKARHTR6PIK3C3 | |
| SCHEMBL20765228 | 0.79 | HTR6 (0.43) | PTGDR2CYP2C19HTR6PIK3C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339970-A1 | CASEIN KINASE 1 DELTA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-26 | — | — | US | disclosed |
| US-20230339970-A1 | CASEIN KINASE 1 DELTA MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2023-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339970-A1 | CASEIN KINASE 1 DELTA MODULATORS | CSNK1D, CSNK1A1, CSNK1G1 | PTGDR2 1069/4885SRC 363/4885CYP2C19 3239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.